187 related articles for article (PubMed ID: 29868920)
21. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
22. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
[TBL] [Abstract][Full Text] [Related]
23. Ki-67 labeling index and the grading of cerebral gliomas by using intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling magnetic resonance imaging.
Wang C; Dong H
Acta Radiol; 2020 Aug; 61(8):1057-1063. PubMed ID: 31830431
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnostic value of 3.0T MR 3D-ASL technique for recurrence and pseudo-progression of high-grade glioma.
Chen YS; Zheng SY; Huang LL; Xu YG; Chen SQ; Zhan AL
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):679-686. PubMed ID: 38305610
[TBL] [Abstract][Full Text] [Related]
25. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
27. Assessment of glioma response to radiotherapy using 3D pulsed-continuous arterial spin labeling and 3D segmented volume.
Wang P; Li J; Diao Q; Lin Y; Zhang J; Li L; Yang G; Fang X; Li X; Chen Y; Zheng L; Lu G
Eur J Radiol; 2016 Nov; 85(11):1987-1992. PubMed ID: 27776650
[TBL] [Abstract][Full Text] [Related]
28. Arterial spin labelling and diffusion-weighted imaging in paediatric brain tumours.
Hales PW; d'Arco F; Cooper J; Pfeuffer J; Hargrave D; Mankad K; Clark C
Neuroimage Clin; 2019; 22():101696. PubMed ID: 30735859
[TBL] [Abstract][Full Text] [Related]
29. Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment.
Nyberg E; Honce J; Kleinschmidt-DeMasters BK; Shukri B; Kreidler S; Nagae L
Neuroradiol J; 2016 Oct; 29(5):377-83. PubMed ID: 27542895
[TBL] [Abstract][Full Text] [Related]
30. [Quantitative evaluation of intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling in Ki-67 labeling index and grading of brain gliomas].
Wang CC; Dong HB; Ding F; Li YD; Wang GY; Ding HX
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(5):338-342. PubMed ID: 30772973
[No Abstract] [Full Text] [Related]
31. Combination of three-dimensional arterial spin labeling and stretched-exponential model in grading of gliomas.
Qu Y; Zhou L; Jiang J; Quan G; Wei X
Medicine (Baltimore); 2019 Jun; 98(25):e16012. PubMed ID: 31232933
[TBL] [Abstract][Full Text] [Related]
32. Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence.
Zhang J; Wu Y; Wang Y; Zhang X; Lei Y; Zhu G; Mao C; Zhang L; Ma L
Eur Radiol; 2023 May; 33(5):3332-3342. PubMed ID: 36576544
[TBL] [Abstract][Full Text] [Related]
33. Crossed cerebellar diaschisis in post-treatment glioma patients: A comparative study of arterial spin labelling and dynamic susceptibility contrast.
Lin T; Lyu Y; Qu J; Cheng X; Fan X; Zhang Y; Hou B; You H; Ma W; Feng F
Eur J Radiol; 2018 Oct; 107():70-75. PubMed ID: 30292276
[TBL] [Abstract][Full Text] [Related]
34. Arterial Spin Labeling to Predict Brain Tumor Grading in Children: Correlations between Histopathologic Vascular Density and Perfusion MR Imaging.
Dangouloff-Ros V; Deroulers C; Foissac F; Badoual M; Shotar E; Grévent D; Calmon R; Pagès M; Grill J; Dufour C; Blauwblomme T; Puget S; Zerah M; Sainte-Rose C; Brunelle F; Varlet P; Boddaert N
Radiology; 2016 Nov; 281(2):553-566. PubMed ID: 27257950
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of Parenchymal Cerebral Blood Flow Measurements Using Pseudocontinuous Arterial Spin-Labeling in Healthy Volunteers.
Ambarki K; Wåhlin A; Zarrinkoob L; Wirestam R; Petr J; Malm J; Eklund A
AJNR Am J Neuroradiol; 2015 Oct; 36(10):1816-21. PubMed ID: 26251434
[TBL] [Abstract][Full Text] [Related]
36. Capability of arterial spin labeling MR imaging in localizing seizure focus in clinical seizure activity.
Kim BS; Lee ST; Yun TJ; Lee SK; Paeng JC; Jun J; Kang KM; Choi SH; Kim JH; Sohn CH
Eur J Radiol; 2016 Jul; 85(7):1295-303. PubMed ID: 27235877
[TBL] [Abstract][Full Text] [Related]
37. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
[TBL] [Abstract][Full Text] [Related]
38. Arterial Spin-Labeling Improves Detection of Intracranial Dural Arteriovenous Fistulas with MRI.
Amukotuwa SA; Marks MP; Zaharchuk G; Calamante F; Bammer R; Fischbein N
AJNR Am J Neuroradiol; 2018 Apr; 39(4):669-677. PubMed ID: 29545245
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of three-dimensional arterial spin labeling and how it compares against that of contrast enhanced magnetic resonance imaging in preoperative grading of brain gliomas.
Wang K; Guo H; Tian X; Miao Y; Han P; Jin F
Environ Toxicol; 2023 Jul; 38(7):1723-1731. PubMed ID: 37040330
[TBL] [Abstract][Full Text] [Related]
40. Arterial Spin Labeling Method as a Supplemental Predictor to Distinguish Between High- and Low-Grade Gliomas.
Komatsu K; Wanibuchi M; Mikami T; Akiyama Y; Iihoshi S; Miyata K; Sugino T; Suzuki K; Kanno A; Noshiro S; Ohtaki S; Mikuni N
World Neurosurg; 2018 Jun; 114():e495-e500. PubMed ID: 29530684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
